SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

IMG Crypto is trending as community members highlight its real-time SOL yield rewards and transparent, community-driven protocol. Discussion emphasizes the passive income potential for holders, with rewards distributed directly to wallets, and its resilience in the crypto space. The community also notes upcoming events and the protocol's continued development.

Aventus Network

Aventus Network ($AVT) is trending as the community discusses its potential, real-world technology, and partnerships within the blockchain space, particularly its interoperability with Polkadot ($DOT). Some users are speculating about potential gains similar to other altcoins and expressing surprise at its current market cap relative to its perceived value and tech. General altcoin season sentiment may also be contributing to the increased interest.

CTX is a governance token that powers and secures the Cryptex protocol. Holders of CTX can vote on protocol upgrades for TCAP as well as all future products within the Cryptex ecosystem.

Cryptex Finance

Cryptex Finance's CTX token is gaining attention as traders discuss its potential for significant gains due to its low float and market cap, with some drawing comparisons to similar tokens like AVT.  The community speculates on upcoming news and developments, including the launch of TCAP, and its potential impact on CTX's price. Some traders express frustration with perceived lack of communication from the Cryptex team, while others highlight the potential for a squeeze given the token's fundamentals.

faithcoin

FaithCoin is trending as community members promote its availability on Phantom Wallet and encourage others to invest. Discussion centers on the intersection of belief and profit, with supporters highlighting the coin's positive chart performance. The coin is frequently mentioned alongside Solana, Bitcoin, and Pepe.

Bounce Token

AUCTION CRYPTO (Bounce Token) is trending as traders discuss its potential for significant moves, highlighting its solid fundamentals and active development team. The community is focused on stacked bids and the possibility of a breakout, with some suggesting it's undervalued and poised for substantial gains. Discussions also mention its potential integration with auctions/NFTs, drawing attention to its use case within the crypto space.

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.

Cns Pharmaceuticals Inc

CNSP is trending due to news of securing Orphan Drug Designation transfer for TPI 287, a treatment for brain cancer, sparking significant volume and discussions of a potential squeeze. Community members are actively debating the stock's potential, its history of reverse splits, and the impact of a recent public offering. Some traders express optimism for a run to higher price levels, while others remain skeptical due to the company's past performance and dilution concerns.

Direxion Shares ETF Trust - Direxion Daily Gold Miners Index Bear -2X Shares

Direxion Daily Gold Miners Index Bear 2X Shares

DUST is trending as traders discuss potential pullbacks in gold and gold miners, debating whether recent strength is sustainable or if it's a short-term buying opportunity. Community members are weighing macro factors like real yields and Fed policy against seasonal demand, while others suggest using puts on GLD or GDX as alternatives to DUST. Concerns about DUST's inherent decay and suitability for longer-term holds are also prevalent.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

Polkadot is trending as the community debates its future amid discussions around interoperability, tokenomics, and potential catalysts, including Aventus integration and real-world partnerships. Some traders express concerns over its current price action and compare it to other struggling projects, while others remain optimistic about staking and long-term growth, citing potential benefits from a capped supply and upcoming Web3 developments. The potential for an altcoin season and the impact of macroeconomic factors like interest rate cuts are also being weighed by investors.

Toll Brothers, Inc. engages in the design, building, marketing, and arranging of financing for detached and attached homes in residential communities. It operates through the following geographical segments: North Region, Mid-Atlantic Region, South Region, Mountain Region, and Pacific Region. The company was founded by Robert I. Toll, and Bruce E. Toll in May 1967 and is headquartered in Fort Washington, PA.

Toll Brothers Inc.

Toll Brothers is trending as investors assess the luxury homebuilder's prospects amidst shifting market dynamics, with call options activity suggesting bullish sentiment. Community discussions focus on whether Toll Brothers can maintain its strong performance amid headwinds like affordability concerns and fluctuating interest rates. Analysts are weighing in with revised ratings and price targets, adding to the stock's visibility.

D.R. Horton, Inc. engages in the construction and sale of single-family housing. It operates through the following geographical segments: Northwest, Southwest, South Central, Southeast, East, and North. The Northwest segment relates to Colorado, Oregon, Utah, and Washington. The Southwest segment covers Arizona, California, Hawaii, Nevada, and New Mexico. The South Central segment is involved in Arkansas, Oklahoma, and Texas. The Southeast segment refers to Alabama, Florida, Louisiana, and Mississippi. The East segment operates Georgia, North Carolina, South Carolina, and Tennessee. The North segment focuses on Delaware, Illinois, Indiana, Iowa, Kentucky, Maryland, Minnesota, Nebraska, New Jersey, Ohio, Pennsylvania, Virginia, and West Virginia. The company was founded by Donald Ray Horton in 1978 and is headquartered in Arlington, TX.

D.R. Horton Inc.

DHI is trending as option traders show interest with heavy call option flow, while analysts recently downgraded the stock. The community is discussing whether this activity signals a potential turnaround or if traders are overlooking fundamental concerns.  Overall, the home construction sector and related stocks are being closely watched.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Incyte Announces Phase 1 Results for its TGFR2PD-1 Bispecific Antibody in Advanced Colorectal Cancer and KRAS G12D Inhibitor in Advanced Pancreatic Ductal Adenocarcinoma

Incyte (Nasdaq:INCY) announced the first clinical data evaluating its TGFR2PD-1 bispecific antibody (INCA33890) for patients with microsatellite stable (MSS) colorectal cancer; and its potent...

INCY or ARGX: Which Is the Better Value Stock Right Now?

INCY vs. ARGX: Which Stock Is the Better Value Option?

Data from Incytes TGFR2PD-1 Bispecific Antibody and KRAS G12D Inhibitor to be Presented at the European Society of Medical Oncology (ESMO) Congress 2025

Incyte (Nasdaq:INCY) today announced that results from Phase 1 proof-of-concept studies of INCA33890, a promising TGFR2PD-1-directed bispecific antibody, and INCB161734, a novel, selective and orally...

Abbott to Report Q3 Earnings: Medical Devices Arm in Focus

ABT's Q3 results may show strength in Medical Devices and Nutrition, offsetting softness in Diagnostics.

TLRY Gears Up to Report Q1 Earnings: Cannabis Recovery in Focus

Tilray Brands' fiscal first-quarter report is likely to highlight international cannabis gains, European expansion and wellness growth.

Will Incyte (INCY) Beat Estimates Again in Its Next Earnings Report?

Incyte (INCY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Strength Seen in Oculis Holding AG (OCS): Can Its 6.7% Jump Turn into More Strength?

Oculis Holding AG (OCS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

INCY Obtains FDA Approval for Label Expansion of Ruxolitinib Cream 

Incyte secures FDA nod for Opzeluras pediatric use in atopic dermatitis, marking its third U.S. approval and boosting sales momentum. 

INCY Announces New Late-Stage Data on Skin Disease Drug

Incyte's povorcitinib shows strong 24-week STOP-HS data in hidradenitis suppurativa, supporting 2025-2026 regulatory filings.

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.

Incyte Corp.

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

INCY
Incyte Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest INCY News

INCYIncyte Corp.